Biomaterials to enhance the efficacy of MSCs for rotator cuff repair
Biomaterials to enhance the efficacy of MSCs for rotator cuff repair
批准号:
10295835
负责人:
Athanasios Mantalaris
金额:
$38.57万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-01 至 2026-04-30
关键词:
21 year oldAddressAffectAftercareAtrophicBiochemicalBiocompatible MaterialsBiological AssayCell AgingCell Surface ReceptorsCell TherapyCell TransplantationCellsCellular Metabolic ProcessClinicalDiseaseEarly identificationElderlyEngineeringEnzyme-Linked Immunosorbent AssayFlow CytometryGene ExpressionGeneral PopulationGlycosaminoglycansGoalsHeterogeneityHistologyHumanHydrogelsIn SituIn VitroInjectionsInjuryIntegrinsIsometric ExerciseLaboratoriesLeadLigandsMeasuresMechanicsMesenchymalMetabolicMetabolismMethodologyMethodsMissionModelingModulusMuscleMuscle functionMusculoskeletal DiseasesMyoblastsN-CadherinNatural regenerationOperative Surgical ProceduresOutcomeOutcome MeasurePathway AnalysisPatient-Focused OutcomesPhasePopulationProductionPropertyPublic HealthRattusRegenerative MedicineResearchRoleRotator CuffSiteStainsStromal CellsStyrenesTechniquesTendon structureTestingTherapeuticTimeTissuesTransplantationUnited States National Institutes of HealthWorkangiogenesisappropriate dosebasebeta-Galactosidasedesignexperimental studyfitnesshealingimmunoregulationimprovedin vitro Assayin vivoinnovationmacrophagemetabolomicsmigrationmonocytemuscle degenerationmuscle regenerationrecruitregenerativerepairedresponserotator cuff injuryrotator cuff tearscreeningsenescenceshoulder injurystem cell expansionstem cell therapystem cellssupraspinatus musclesurgery outcometissue culturetissue regenerationtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
Rotator cuff tears are present in approximately 20% of the population and result in mechanical
unloading of the rotator cuff muscle. As a result, the muscle undergoes atrophy, which negatively impacts
clinical outcomes of surgical repair. Recent work has shown reduction in rotator cuff muscle
degeneration after transplantation of mesenchymal-derived stem cells (MSCs). However, MSC-based
therapies for musculoskeletal diseases have been plagued by sub-optimal efficacy, due, in part, to lack of
effective methods to 1) reach therapeutically relevant numbers of highly potent cells, and 2) retain cells
at the site of injury once transplanted. Therefore, we hypothesize that that culture and injection of MSCs
on microparticle carriers designed to promote therapeutic potency (reduced senescence and a pro-
regenerative secretome) will result in greater cellular retention in the damaged muscle, and improved
supraspinatus muscle regeneration after tendon reattachment.
The objective of this application is to determine 1) the relationship between biomaterial carrier
properties, cell metabolism, and therapeutic fitness of seeded MSCs, and 2) how transplanting cells with
high fitness on materials to improve local retention ultimately affects the level of regeneration of rotator
cuff muscle after surgical repair of the torn tendon. This objective will be approached through the
following specific aims: 1) Evaluate the effects of altering the biochemical composition of the biomaterial
carrier on metabolism and replicative senescence of human MSCs during expansion, 2) Evaluate effects
of altering the biochemical composition of the biomaterial carrier on secretion of pro-regenerative factors
by human MSCs, and 3) Evaluate the effects of transplantation of MSCs after culture on carriers
determined from Aims 1&2 on regeneration in the rat supraspinatus muscle after tendon reattachment.
The proposed work is innovative because it focuses on design of material substrates to engineer the
secretome of transplanted cells in order to promote tissue healing after rotator cuff tear, as well as
provides an important early metabolomics-based screening technique for the effects of substrate
properties on cellular therapeutic fitness. Results from these studies are expected to have an important
positive impact because they will lead to more efficacious regenerative medicine therapies for rotator cuff
tears, and may further lead to more effective cell-based therapies for a wide variety of diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Precision Medicine Tool for Optimal Personalized Treatment in Patients with Acute Myeloid Leukemia
-
批准号:10547266
-
项目类别:
-
资助金额:$39.69万
-
财政年份:2022
-
负责人:Athanasios Mantalaris
-
依托单位:
海外基金